Skip to main content

Military Health System

Utility Navigation Links

TRICARE Policy Manual 6010.60-M, April 1, 2015
Chapter 7
Section 2.4
Cervical Cancer Screening
Issue Date:  February 23, 1994
Authority:  32 CFR 199.4(g)(1), (g)(2), and (g)(37)
Copyright:  CPT only © 2006 American Medical Association (or such other date of publication of CPT). All Rights Reserved.
Revision:  C-9, October 20, 2017
88141 - 88155, 88164 - 88167, 99201 - 99215 or 99301 - 99313
Papanicolaou (PAP) test is an exfoliative cytological staining procedure for the detection and diagnosis of various conditions, particularly malignant and premalignant conditions of the female genital tract. PAP tests are performed as either a diagnostic or screening test. For TRICARE purposes diagnostic PAP tests are tests performed on symptomatic females presenting with signs or symptoms of malignant or premalignant disease or pregnancy; screening PAP tests are performed on asymptomatic females who do not present with signs or symptoms of cervical or medical disease.
Cervical PAP tests are covered on either a diagnostic or screening basis. (For additional information on screening PAP tests, see the Clinical Preventive Services sections in Chapter 7.)
- END -
$(document).ready(function() { $('div.Form').prepend(''); jQuery('.close_button').click(function() { jQuery('div.print_notice').addClass('invisible');}); });
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery